[长期双膦酸盐治疗骨质疏松症的疗效和安全性]

Clinical calcium Pub Date : 2017-01-01
Takami Miki
{"title":"[长期双膦酸盐治疗骨质疏松症的疗效和安全性]","authors":"Takami Miki","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Bisphosphonates can be administered by various ways, and number of patient under bisphosphonate treatment for longer periods is increasing. As bisphosphonates remain inside body for long period, and continue to suppress bone resorption, careful observation is required to these patients. Recent reports show 5-10 year-treatment is safe and keep reduction of the fracture risk without increase of the adverse effects. On the other hand, interruption of the treatment of 2-5 years does not reduce the effectiveness for bone turnover, bone mineral density, and/or fractures. Therefore, bisphosphonate treatment can be interrupted after longer periods of treatment except patients with high fracture risks. We need more scientific date for the prevention of atypical fracture, and reasonable levels of bone turnover and periods of the suppression.</p>","PeriodicalId":502100,"journal":{"name":"Clinical calcium","volume":"27 2","pages":"239-246"},"PeriodicalIF":0.0000,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Efficacy and safety of long-term bisphosphonate treatment for osteoporosis.]\",\"authors\":\"Takami Miki\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Bisphosphonates can be administered by various ways, and number of patient under bisphosphonate treatment for longer periods is increasing. As bisphosphonates remain inside body for long period, and continue to suppress bone resorption, careful observation is required to these patients. Recent reports show 5-10 year-treatment is safe and keep reduction of the fracture risk without increase of the adverse effects. On the other hand, interruption of the treatment of 2-5 years does not reduce the effectiveness for bone turnover, bone mineral density, and/or fractures. Therefore, bisphosphonate treatment can be interrupted after longer periods of treatment except patients with high fracture risks. We need more scientific date for the prevention of atypical fracture, and reasonable levels of bone turnover and periods of the suppression.</p>\",\"PeriodicalId\":502100,\"journal\":{\"name\":\"Clinical calcium\",\"volume\":\"27 2\",\"pages\":\"239-246\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical calcium\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical calcium","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

双膦酸盐可以通过多种方式给药,长期接受双膦酸盐治疗的患者数量正在增加。由于双膦酸盐在体内滞留时间较长,持续抑制骨吸收,需要对这些患者进行仔细观察。最近的报告显示,5-10年的治疗是安全的,并且在不增加不良反应的情况下保持骨折风险的降低。另一方面,中断治疗2-5年并不会降低骨转换、骨矿物质密度和/或骨折的有效性。因此,除了骨折风险高的患者外,双膦酸盐治疗可以在治疗较长时间后中断。我们需要更科学的数据来预防非典型骨折,合理的骨转换水平和抑制时间。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
[Efficacy and safety of long-term bisphosphonate treatment for osteoporosis.]

Bisphosphonates can be administered by various ways, and number of patient under bisphosphonate treatment for longer periods is increasing. As bisphosphonates remain inside body for long period, and continue to suppress bone resorption, careful observation is required to these patients. Recent reports show 5-10 year-treatment is safe and keep reduction of the fracture risk without increase of the adverse effects. On the other hand, interruption of the treatment of 2-5 years does not reduce the effectiveness for bone turnover, bone mineral density, and/or fractures. Therefore, bisphosphonate treatment can be interrupted after longer periods of treatment except patients with high fracture risks. We need more scientific date for the prevention of atypical fracture, and reasonable levels of bone turnover and periods of the suppression.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信